-
China refines its Hatch-Waxman counterpart as Beijing IP Court highlights nine pharma patent cases
Read more: China refines its Hatch-Waxman counterpart as Beijing IP Court highlights nine pharma patent casesNine selected Beijing IP Court cases clarify pharmaceutical patent protection and the operation of China’s Hatch-Waxman counterpart, addressing claim scope, the boundaries of linkage litigation and generic applicants’ declarations and evidence.
-
Access Advance to slash discounts available to dual HEVC and VVC licensees who sign up to bridging agreement from next year
Read more: Access Advance to slash discounts available to dual HEVC and VVC licensees who sign up to bridging agreement from next yearThose who sign the Multi Codec Bridging Agreement on or before December 31, 2026 could still get an effective royalty discount of up to 50%.
-
InterDigital Chief Legal Officer Josh Schmidt: antitrust has “limited role” in SEP FRAND disputes
Read more: InterDigital Chief Legal Officer Josh Schmidt: antitrust has “limited role” in SEP FRAND disputesIn an exclusive interview with ip fray, Mr. Schmidt discusses InterDigital’s global patent infringement case against Disney, his views on the diverging approaches of different courts and their impact on SEP litigation, the role of antitrust in SEP FRAND disputes, and using arbitration versus mediation as alternative dispute resolution mechanisms.
-
Brazilian court gives weight to German FRAND decisions in IP Bridge v. Transsion
Read more: Brazilian court gives weight to German FRAND decisions in IP Bridge v. TranssionA court in Rio has rejected a fresh economic examination of Via Licensing Alliance’s AVC patent pool licensing terms, relying on earlier German judgments and Brazilian appellate authority in a decision highlighting the growing influence of prior FRAND rulings.
-
UPC Hague LD finds Pfizer/BioNTech’s Comirnaty infringes GSK liposome patent; grants pan-European injunction but defers enforcement
Read more: UPC Hague LD finds Pfizer/BioNTech’s Comirnaty infringes GSK liposome patent; grants pan-European injunction but defers enforcementThe UPC Hague LD upheld 12 claims of GSK’s liposome patent, finding that Pfizer and BioNTech’s Comirnaty vaccine infringes six of them. It revoked one medical-use claim for insufficiency and granted a pan-European injunction, subject to deferred enforcement.
-
Pictiva sues BOE in Texas after Samsung settlement that followed $191M jury verdict
Read more: Pictiva sues BOE in Texas after Samsung settlement that followed $191M jury verdictPictiva Displays International, an affiliate of Key Patent Innovations, has accused the Chinese company of infringing five patents relating to OLED display technology.
-
UPC infringement filings reach 2026 high of 40 in October, German divisions’ monthly share falls to 67.5%
Read more: UPC infringement filings reach 2026 high of 40 in October, German divisions’ monthly share falls to 67.5%The UPC also logged 11 new stand-alone revocation actions, five provisional measures applications, and 69 first-instance cases overall in October 2026, while The Hague had its busiest month of the year.
-
UPC Milan accepts parent-company guarantee in Nixu v. Amazon security-for-costs dispute
Read more: UPC Milan accepts parent-company guarantee in Nixu v. Amazon security-for-costs disputeThe UPC’s Milan Local Division has rejected Amazon’s €600,000 security-for-costs request against Nixu, finding that a parent-company guarantee provides sufficient protection despite potential enforcement complications under Texas law.
Follow Us
Latest Articles
- China refines its Hatch-Waxman counterpart as Beijing IP Court highlights nine pharma patent cases
- Access Advance to slash discounts available to dual HEVC and VVC licensees who sign up to bridging agreement from next year
- InterDigital Chief Legal Officer Josh Schmidt: antitrust has “limited role” in SEP FRAND disputes
- Brazilian court gives weight to German FRAND decisions in IP Bridge v. Transsion
- UPC Hague LD finds Pfizer/BioNTech’s Comirnaty infringes GSK liposome patent; grants pan-European injunction but defers enforcement